Have a personal or library account? Click to login
The Correlation of Hemostatic Parameters with the Development of Early Sepsis-Associated Encephalopathy. A Retrospective Observational Study Cover

The Correlation of Hemostatic Parameters with the Development of Early Sepsis-Associated Encephalopathy. A Retrospective Observational Study

Open Access
|Oct 2024

Figures & Tables

Fig. 1.

Comparison of coagulation initiation between groups.
Comparison of coagulation initiation between groups.

Fig. 2.

Comparison of coagulation propagation between groups.
Comparison of coagulation propagation between groups.

Fig. 3.

Comparison of clot strength between groups.
Comparison of clot strength between groups.

Multivariate logistic regression model using age and complete blood count parameters_

ParameterAdjusted OR95% CIP value
Leucocyte count1.0001.000; 1.0000.403
Platelet count1.0031.001; 1.0060.004*
Age1.0030.987; 1.0200.710

Demographic data and complete blood count parameters in patients with and without sepsis-associated encephalopathy (SAE)_

ParameterPatients with SAE (n=184)Patients without SAE (n=96)Reference rangesP value
Age (years)73 (18)70 (16) 0.088
Male sex94 (51.08%)52 (54.16%) 0.624
Leucocyte count (per μL)14100 (10960)10265 (10882)4000–90000.003*
Hemoglobin (g/dL)10.1 (3.9)9.8 (3.8)11.5–170.276
Platelet count (per μL)200000 (166500)128500 (149500)150000–400000<0.001*

Multivariate logistic regression model using fibrinogen levels and platelet contribution to clot strength_

ParameterAdjusted OR95% CIP value
Fibrinogen level1.0000.997; 1.0020.403
Platelet component1.0071.001; 1.0130.02*

Hemostatic tests in patients with and without sepsis-associated encephalopathy (SAE)_

ParameterPatients with SAE (n=63)Patients without SAE (n=55)Reference rangesP value
PT (s)15.95 (3.8)17 (5.2)10.4–14.30.440
Fibrinogen (mg/dL)431.88 (±198.14)373.94 (±170.94)200–4000.095
Factor II (%)57.46 (±15.12)57.07 (±14.73)70–1200.888
Factor V (%)54.35(±19.13)52.70 (±18.10)70–1200.635
Factor VII (%)36.33(±13.78)37.61(±15.54)55–1650.638
Factor X (%)56.34(±16.40)54.67(±15.62)70–1200.579
AT (%)65.44(±17.85)68.25(±14.45)80–1200.389
PC (%)58.98(±11.94)60.06(±13.71)70–1500.663
PS (%)44.86(±10.08)43.68(±12.04)60–1400.581
D-dimer (ng/mL)4830.5 (6273)3940 (7493)<5000.446
EXTEM CT (s)69 (20.5)70.5 (22.8)38–790.791
EXTEM CFT (s)90.5 (80)114.5 (104)34–1590.001*
EXTEM MCF (mm)64.30(±14.41)56.71(±12.60)50–720.004*
EXTEM MCE218.81(±126.33)147.85(±73.31)-0.001*
EXTEM CLI60 (%)98(3)98(4)>850.167
MaxVel (mm/min)17 (9.8)14 (10)11–25a0.021*
t-MaxVel (s)85 (69.5)99 (105.5)147–223a0.931
AUC (mm x 100)6360.16(±1364.86)5602.31(±1269.07)-0.005*
FIBTEM MCF (mm)21.71(±11.40)16.40(±7.78)9–250.007*
FIBTEM MCE38.44 (±53.24)20.66 (±13.23)-0.024*
APTEM CLI60 (%)98 (3)98 (4)-0.278
Diff CLI600 (0)0 (1)-0.374
Platelet component175.5 (156.75)119.5 (105)-0.010*
DOI: https://doi.org/10.2478/jccm-2024-0040 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 329 - 336
Submitted on: Feb 28, 2024
|
Accepted on: Sep 28, 2024
|
Published on: Oct 31, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Florin Scarlatescu, Ecaterina Scarlatescu, Dana Rodica Tomescu, Daniela Bartos, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.